Literature DB >> 12940087

[Expression of CD44 variant exon 6 in lung cancers].

F L Wang1, L X Wei.   

Abstract

Immunohistochemical staining was carried out on 79 samples of lung cancers using anti-CD44v6 antibody. Strong positivity for CD44v6 was observed in the basal cells of bronchial epithelium, squamous metaplasia, and type II pneumocytes. The expression of CD44v6 in primary lesions of non-small cell lung cancers and small cell lung cancers was 67.6% (48/71) and 0% (0/8) respectively, while the expression of CD44v6 in metastases of lymph nodes was 57.6% (19/33) and 0% (0/5), respectively. It is suggest that expression of CD44v6 is correlated with histologic type, differentiation and metastasis of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12940087

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  3 in total

1.  The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA.

Authors:  Gang Zhou; David Chiu; Dajiang Qin; Lizhi Niu; Jinlei Cai; Lihua He; Wenhao Huang; Kecheng Xu
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

2.  Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.

Authors:  Yong-Jun Liu; Pei-Song Yan; Jun Li; Jing-Fen Jia
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

3.  Selectins mediate small cell lung cancer systemic metastasis.

Authors:  Franziska Heidemann; Anna Schildt; Katharina Schmid; Oliver T Bruns; Kristoffer Riecken; Caroline Jung; Harald Ittrich; Daniel Wicklein; Rudolph Reimer; Boris Fehse; Joerg Heeren; Georg Lüers; Udo Schumacher; Markus Heine
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.